Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses

An effective vaccine for respiratory syncytial virus (RSV) is an unrealized public health goal. A single dose of the prefusion-stabilized fusion (F) glycoprotein subunit vaccine (DS-Cav1) substantially increases serum-neutralizing activity in healthy adults. We sought to determine whether DS-Cav1 va...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Immunity
Prif Awduron: Mukhamedova, Maryam, Wrapp, Daniel, Shen, Chen-Hsiang, Gilman, Morgan S.A., Ruckwardt, Tracy J., Schramm, Chaim A., Ault, Larissa, Chang, Lauren, Derrien-Colemyn, Alexandrine, Lucas, Sarah A.M., Ransier, Amy, Darko, Samuel, Phung, Emily, Wang, Lingshu, Zhang, Yi, Rush, Scott A., Madan, Bharat, Stewart-Jones, Guillaume B.E., Costner, Pamela J., Holman, LaSonji A., Hickman, Somia P., Berkowitz, Nina M., Doria-Rose, Nicole A., Morabito, Kaitlyn M., DeKosky, Brandon J., Gaudinski, Martin R., Chen, Grace L., Crank, Michelle C., Misasi, John, Sullivan, Nancy J., Douek, Daniel C., Kwong, Peter D., Graham, Barney S., McLellan, Jason S., Mascola, John R.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2021
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8099422/
https://ncbi.nlm.nih.gov/pubmed/33823129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.immuni.2021.03.004
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg